0.854USD+0.854æéå€ååŒÂ 07/31, 20:00 (ET)
1.53MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
äž»èŠããŒã¿
0.860å§å€
0.860é«å€
19.31Kåºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
æå€±é¡äºæ³PER
--çŽè¿12ã¶æé
åœ
1.08%売買å転ç
0.860忥çµå€
0.830å®å€
11.49K売買代é
æå€±é¡æ ªäŸ¡åçç
0.25PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-70.21%ç·è³ç£å©çç
6.75052é±é«å€
0.52åºæ¥é«æ¯ç%
-7.32MçŽå©ç
1.80Mæ ªåŒæ°
-1.15581æ ªåœããå©çïŒEPSïŒ
0.93ããŒã¿å€
-75.40%èªå·±è³æ¬å©çç
1.05052é±å®å€
3.49%æ¯ãå¹
--ç²å©çç
1.53MæäŸ¡ç·é¡
-9.22ãªã¹ã¯ãªã¿ãŒã³
4.28%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-30 äž»èŠã€ã³ãµã€ã
Bone Biologics Corpã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸãããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã§ã®é äœã¯384äž197äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ãããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯12.20ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžéãã¬ã³ããšäºæ³ãããŸããæ ªåŒåžå Žã§ã®ããã©ãŒãã³ã¹ã¯ãã®1ãæã§éåžžã«äœèª¿ã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Bone Biologics Corpã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Bone Biologics Corpã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Bone Biologics Corp ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Ionis Pharmaceuticals Inc
IONS
25
ææšî
ææš
売ã(3)
äžç«(0)
è²·ã(0)
ç§»åå¹³å
売ã(6)
äžç«(0)
è²·ã(0)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Bone Biologics Corpã®äŒæ¥æ
å ±î
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
äŒæ¥ã³ãŒãBBLG
äŒæ¥åBone Biologics Corp
æé«çµå¶è²¬ä»»è
ãCEOãFrelick (Jeffrey)
ãŠã§ããµã€ãhttps://www.bonebiologics.com/
æ ªäž»çµ±èšî
ãããã質å
Bone Biologics CorpïŒBBLGïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îBone Biologics CorpïŒBBLGïŒã®çŸåšã®æ ªäŸ¡ã¯0.85ã§ãã
Bone Biologics Corpã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îBone Biologics Corpã®ãã£ãã«ãŒã·ã³ãã«ã¯BBLGã§ãã
Bone Biologics Corpã®52é±é«å€ã¯ãããã§ããïŒ
îBone Biologics Corpã®52é±é«å€ã¯6.75ã§ãã
Bone Biologics Corpã®52é±å®å€ã¯ãããã§ããïŒ
îBone Biologics Corpã®52é±å®å€ã¯1.05ã§ãã
Bone Biologics Corpã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îBone Biologics Corpã®æäŸ¡ç·é¡ã¯1.53Mã§ãã
Bone Biologics Corp (BBLG) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îBone Biologics CorpïŒBBLGïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-2.65ã§ãã